Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AbstractElevated plasma total homocysteine (tHcy) is a risk factor for various disorders. We investigated whether functional polymorphisms in catechol‐O‐methyltransferase (COMT) influence tHcy, since COMT activity producesS‐adenosylhomocysteine (SAH), a homocysteine precursor. We hypothesized that high activity COMT variants would be associated with high tHcy, since they presumably result in increased formation of SAH. We genotyped 780 community‐dwelling elderly individuals for functionalCOMT(Val158Met and A−287G) and methylenetetrahydrofolate reductase (MTHFR; C677T) polymorphisms, and measured plasma tHcy. As predicted,COMTVal158carriers had significantly higher tHcy than Met158homozygotes. The effect was limited to individuals homozygous for theMTHFRT677allele. In addition, individuals homozygous for theCOMTG−287allele tended to have lower tHcy levels. High activity variants ofCOMTinteract with the low activity variant ofMTHFRto increase tHcy levels. The effect on tHcy may contribute to the reported associations of COMT genotype with psychiatric and neurobiological phenotypes. The results also indicate that COMT activity may influence a broader range of biochemical pathways than hitherto appreciated. © 2008 Wiley‐Liss, Inc.

Original publication

DOI

10.1002/ajmg.b.30700

Type

Journal article

Journal

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Publisher

Wiley

Publication Date

05/09/2008

Volume

147B

Pages

996 - 999